Melanoma Awareness Month: Why Early Detection and Objective Skin Health Measurement Matter More Than Ever
May is Skin Cancer Awareness Month, a time dedicated to education, prevention, and early detection of the most common cancer in the United States. While all skin cancers deserve attention, melanoma remains the most dangerous form due to its ability to spread quickly if not detected early.
The good news is that melanoma is highly treatable when caught early. In fact, the five-year survival rate exceeds 99% when detected at an early stage. That statistic alone underscores a critical truth: early detection is life-saving.
But detection today still relies heavily on what we can see. And that’s where the opportunity and the challenge begins.
Understanding Melanoma: What to Look For
Melanoma develops when pigment-producing cells (melanocytes) grow uncontrollably. It often appears as a new mole or a change in an existing one. Clinicians and patients alike are encouraged to use the ABCDE rule to identify suspicious lesions:
A – Asymmetry: One half doesn’t match the other
B – Border: Irregular, scalloped, or poorly defined edges
C – Color: Variation in color (tan, brown, black, red, white, or blue)
D – Diameter: Typically larger than 6mm (about the size of a pencil eraser)
E – Evolving: Changes in size, shape, or color over time
These visual cues are a powerful starting point. But they also highlight a limitation: they rely on changes that are already visible.
The Problem with Surface-Level Skin Assessment
For decades, skin cancer detection has depended largely on visual examination and subjective interpretation. While clinical expertise is essential, this approach introduces variability:
Differences in clinician experience
Inconsistent lesion interpretation
Limited visibility into what’s happening beneath the skin
Potential delays in identifying early biological changes
The reality is that biology doesn’t start at the surface. In many cases, the earliest signals of melanoma begin below the visible layer of the skin before changes can be easily seen or measured.
This gap between biological change and visual detection is where missed opportunities occur.
Moving Beyond What We Can See
Advancing melanoma detection requires a shift from subjective observation to objective measurement.
At MedX, this shift is central to how we think about skin health innovation. Our approach is rooted in the belief that skin health should be:
Measurable
Objective
Grounded in data
Through non-invasive chromophore imaging, it becomes possible to assess key biological markers beneath the skin’s surface—specifically:
Melanin (pigmentation)
Hemoglobin (blood flow and vascular changes)
Collagen (structural integrity)
These chromophores provide a deeper view into how skin is changing over time, offering insights that go far beyond what the eye alone can detect.
Why This Matters for Melanoma Detection
Melanoma doesn’t always present with obvious visual warning signs in its earliest stages. Subsurface biological changes often occur first, making early detection difficult using traditional methods alone.
By incorporating objective, image-driven skin assessment, clinicians can:
Detect changes earlier
Reduce reliance on subjective interpretation
Improve diagnostic confidence
Identify risk before it becomes visible
Support more timely clinical decisions
This is not about replacing clinical expertise, it’s about enhancing it.
The future of melanoma detection will combine clinical judgment with advanced technology, creating a more precise, scalable, and proactive approach to care.
DermSecure: Advancing Early Detection
As part of the MedX Skin Health ecosystem, DermSecure is designed to support clinicians with deeper insight into the skin.
Rather than relying solely on surface-level evaluation, DermSecure provides:
Images of subsurface biomarkers
Enhanced visibility into early biological changes
Support for more accurate and timely detection
This approach aligns with a broader shift happening across healthcare: moving toward value-based care models that prioritize outcomes, efficiency, and early intervention.
Because when it comes to melanoma, earlier detection leads directly to better outcomes.
What Patients and Providers Can Do Today
While technology continues to evolve, there are important steps everyone can take right now:
For Patients:
Perform regular self-skin checks using the ABCDE rule
Schedule routine skin exams with a dermatologist
Protect your skin from UV exposure (sunscreen, protective clothing)
Pay attention to new or changing lesions
For Providers:
Encourage patient education and routine screenings
Stay informed on emerging diagnostic technologies
Consider how objective measurement tools can enhance care delivery
Focus on early detection as a core clinical priority
A New Standard for Skin Health
Skin Cancer Awareness Month is more than a reminder, let it be a call to action.
If we want to improve melanoma outcomes at scale, we must rethink how skin health is assessed. That means moving beyond what’s visible and embracing tools that provide deeper, more reliable insight into the biology beneath the surface.
At MedX, we believe this is not just an advancement, but the standard.
Because the most important signals in skin health are often the ones we haven’t been measuring.
Explore how MedX Health is redefining skin health through measurable, non-invasive chromophore analysis — and what that means for your clinical, research, or commercial strategy. Move from observation to evidence with MedX.